Investigating the causal nature of the relationship of subcortical brain volume with smoking and alcohol use - Logtenberg, Emma; Overbeek, Martin F; Pasman, Joëlle A; Abdellaoui, Abdel; Luijten, Maartje; van Holst, Ruth J; Vink, Jacqueline M; Denys, Damiaan; Medland, Sarah E; Verweij, Karin JH; Treur, Jorien L (medRxiv, 2020)
Background Structural variation in subcortical brain regions has been linked to substance use, including the most prevalent substances nicotine and alcohol. It may be that pre-existing differences in subcortical brain volume affect smoking and alcohol use, but there is also evidence that smoking and alcohol use can lead to structural changes. We assess the causal nature of this complex relationship with bi-directional Mendelian randomization (MR).Methods MR uses genetic variants predictive of a certain trait (‘exposure’) as instrumental variables to test causal effects on a certain outcome. Due to random assortment at meiosis, genetic variants shouldn’t be associated with confounders, allowing less biased causal inference. We employed summary-level data of the largest available genome-wide association studies of subcortical brain region volumes (nucleus accumbens, amygdala, caudate nucleus, hippocampus, pallidum, putamen, and thalamus; n = 50,290) and smoking and alcohol use (smoking initiation, n = 848,460; cigarettes per day, n = 216,590; smoking cessation, n = 378,249; alcohol drinks per week, n = 630,154; alcohol dependence, n = 46,568). The main analysis, inverse-variance weighted regression, was verified by a wide range of sensitivity methods.Results There was strong evidence that alcohol dependence decreased amygdala and hippocampal volume and that smoking more cigarettes per day decreased hippocampal volume. From subcortical brain volumes to substance use, there was no or weak evidence for causal effects.Conclusions Our findings suggest that heavy alcohol use and smoking can causally reduce subcortical brain volume. This adds to accumulating evidence that alcohol and smoking affect the brain, and most likely mental health, warranting more recognition in public health efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJLT is supported by a Veni grant from the Netherlands Organization for Scientific Research (NWO; grant number 016.Veni.195.016). ML is also supported by a Veni grant from NWO (grant number 451-15-029). KJHV, AA, and JLT are supported by the Foundation Volksbond Rotterdam. AA is supported by ZonMw grant 849200011 from The Netherlands Organisation for Health Research and Development. SEM was supported by NHMRC grants APP1103623, APP1158127 and APP1172917. We acknowledge SURFsara for the usage of the Lisa cluster computer (supported by NWO, 15725).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not relevant as these analyses were based on anonymous, summary-level data of large-scale public datasetsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript reports on analyses which were performed with publicly available summary-level genetic datasets